{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:23:28Z","timestamp":1789647808877,"version":"4.0.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Provincial Science and Technology Guiding Project","award":["2023Y0024"],"award-info":[{"award-number":["2023Y0024"]}]},{"name":"Collaborative Innovation Platform Project for Fuzhou-Xiamen-Quanzhou National Independent Innovation Demonstration Zone","award":["2022-P-028"],"award-info":[{"award-number":["2022-P-028"]}]},{"name":"Clinical Research Center for Precision Diagnosis and Treatment of Neurological Diseases of Fujian Province","award":["2022Y2005"],"award-info":[{"award-number":["2022Y2005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04225-1","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:06:20Z","timestamp":1747641980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative study of nonmotor symptoms in progressive supranuclear palsy and Parkinson\u2019s disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"6","key":"4225_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32(6):853\u201364. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"issue":"12","key":"4225_CR2","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.10583","volume":"18","author":"A Schrag","year":"2003","unstructured":"Schrag A, Selai C, Davis J, Lees AJ, Jahanshahi M, Quinn N. Health-related quality of life in patients with progressive supranuclear palsy. Mov Disord. 2003;18(12):1464\u20139. https:\/\/doi.org\/10.1002\/mds.10583","journal-title":"Mov Disord"},{"issue":"11","key":"4225_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00702-019-02055-3","volume":"126","author":"P Bugalho","year":"2019","unstructured":"Bugalho P, Ladeira F, Barbosa R, Marto JP, Borbinha C, Salavisa M, et al. Motor and non-motor function predictors of mortality in Parkinson\u2019s disease. J Neural Transm (Vienna). 2019;126(11):1409\u201315. https:\/\/doi.org\/10.1007\/s00702-019-02055-3","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"4225_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00415-009-5255-7","volume":"257","author":"C Colosimo","year":"2010","unstructured":"Colosimo C, Morgante L, Antonini A, Barone P, Avarello TP, Bottacchi E, et al. Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol. 2010;257(1):5\u201314. https:\/\/doi.org\/10.1007\/s00415-009-5255-7","journal-title":"J Neurol"},{"issue":"2","key":"4225_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.14802\/jmd.19066","volume":"13","author":"SP Chaithra","year":"2020","unstructured":"Chaithra SP, Prasad S, Holla VV, Stezin A, Kamble N, Yadav R, et al. The Non-Motor symptom profile of progressive supranuclear palsy. J Mov Disord. 2020;13(2):118\u201326. https:\/\/doi.org\/10.14802\/jmd.19066","journal-title":"J Mov Disord"},{"issue":"3","key":"4225_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical E. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235\u201345. https:\/\/doi.org\/10.1016\/S1474-4422(06)70373-8","journal-title":"Lancet Neurol"},{"key":"4225_CR7","doi-asserted-by":"publisher","first-page":"9730319","DOI":"10.1155\/2016\/9730319","volume":"2016","author":"R Ou","year":"2016","unstructured":"Ou R, Song W, Wei Q, Chen K, Cao B, Hou Y, et al. Characteristics of nonmotor symptoms in progressive supranuclear palsy. Parkinsons Dis. 2016;2016:9730319. https:\/\/doi.org\/10.1155\/2016\/9730319","journal-title":"Parkinsons Dis"},{"issue":"1","key":"4225_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41531-017-0037-x","volume":"3","author":"FG Radicati","year":"2017","unstructured":"Radicati FG, Martinez Martin P, Fossati C, Chaudhuri KR, Torti M, Rodriguez Blazquez C, et al. Non motor symptoms in progressive supranuclear palsy: prevalence and severity. NPJ Parkinsons Dis. 2017;3(1):35. https:\/\/doi.org\/10.1038\/s41531-017-0037-x","journal-title":"NPJ Parkinsons Dis"},{"key":"4225_CR9","doi-asserted-by":"publisher","first-page":"106088","DOI":"10.1016\/j.clineuro.2020.106088","volume":"197","author":"A Grazynska","year":"2020","unstructured":"Grazynska A, Urbas W, Antoniuk S, Adamczewska K, Bien M, Chmiela T, et al. Comparative analysis of non-motor symptoms in patients with Parkinson\u2019s disease and atypical parkinsonisms. Clin Neurol Neurosurg. 2020;197:106088. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106088","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"4225_CR10","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"9","key":"4225_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, et al. Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations the movement disorder society task force on rating scales for Parkinson\u2019s disease. Mov Disord. 2004;19(9):1020\u20138. https:\/\/doi.org\/10.1002\/mds.20213","journal-title":"Mov Disord"},{"issue":"15","key":"4225_CR12","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement disorder Society\u2010sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS\u2010UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129\u201370. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Mov Disord"},{"issue":"5","key":"4225_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","volume":"26","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Fitzpatrick R, Fau - Peto V, Peto V, Fau - Greenhall R, Greenhall R, Fau - Hyman N, Hyman N. The Parkinson\u2019s disease questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score. Age Ageing. 1997;26(5):353\u20137. https:\/\/doi.org\/10.1093\/ageing\/26.5.353","journal-title":"Age Ageing"},{"issue":"6","key":"4225_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.clineuro.2009.02.005","volume":"111","author":"G Wang","year":"2009","unstructured":"Wang G, Hong Z, Cheng Q, Xiao Q, Wang Y, Zhang J, et al. Validation of the Chinese Non-Motor symptoms scale for Parkinson\u2019s disease: results from a Chinese pilot study. Clin Neurol Neurosurg. 2009;111(6):523\u20136. https:\/\/doi.org\/10.1016\/j.clineuro.2009.02.005","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"4225_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"4225_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety States by rating. Br J Med Psychol. 1959;32(1):50\u20135. https:\/\/doi.org\/10.1111\/j.2044-8341.1959.tb00467.x","journal-title":"Br J Med Psychol"},{"issue":"4","key":"4225_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1967","unstructured":"Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278\u201396. https:\/\/doi.org\/10.1111\/j.2044-8260.1967.tb00530.x","journal-title":"Br J Soc Clin Psychol"},{"issue":"8","key":"4225_CR18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.parkreldis.2014.04.012","volume":"20","author":"E Antsov","year":"2014","unstructured":"Antsov E, Silveira-Moriyama L, Kilk S, Kadastik-Eerme L, Toomsoo T, Lees A, et al. Adapting the sniffin\u2019 sticks olfactory test to diagnose Parkinson\u2019s disease in Estonia. Parkinsonism Relat Disord. 2014;20(8):830\u20133. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.04.012","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"4225_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.sleep.2011.01.015","volume":"12","author":"T Nomura","year":"2011","unstructured":"Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K. Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson\u2019s disease patients. Sleep Med. 2011;12(7):711\u20133. https:\/\/doi.org\/10.1016\/j.sleep.2011.01.015","journal-title":"Sleep Med"},{"issue":"4","key":"4225_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/mds.23476","volume":"26","author":"C Trenkwalder","year":"2011","unstructured":"Trenkwalder C, Kohnen R, H\u00f6gl B, Metta V, Sixel-D\u00f6ring F, Frauscher B, et al. Parkinson\u2019s disease sleep scale\u2014validation of the revised version PDSS\u20102. Mov Disord. 2011;26(4):644\u201352. https:\/\/doi.org\/10.1002\/mds.23476","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"4225_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jns.2013.01.034","volume":"327","author":"CN Lee","year":"2013","unstructured":"Lee CN, Kim M, Lee HM, Jang JW, Lee SM, Kwon DY, et al. The interrelationship between non-motor symptoms in atypical parkinsonism. J Neurol Sci. 2013;327(1\u20132):15\u201321. https:\/\/doi.org\/10.1016\/j.jns.2013.01.034","journal-title":"J Neurol Sci"},{"issue":"3","key":"4225_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","volume":"8","author":"DR Williams","year":"2009","unstructured":"Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8(3):270\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(09)70042-0","journal-title":"Lancet Neurol"},{"issue":"14","key":"4225_CR23","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/mds.22289","volume":"23","author":"C Schmidt","year":"2008","unstructured":"Schmidt C, Herting B, Fau - Prieur S, Prieur S, Fau - Junghanns S, Junghanns S, Fau - Schweitzer K, Schweitzer K, Fau - Reichmann H, Reichmann H, Fau - Berg D, et al. Autonomic dysfunction in patients with progressive supranuclear palsy. Mov Disord. 2008;23(14):2083\u20139. https:\/\/doi.org\/10.1002\/mds.22289","journal-title":"Mov Disord"},{"issue":"1","key":"4225_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00415-022-11347-w","volume":"270","author":"F Baschieri","year":"2022","unstructured":"Baschieri F, Vitiello M, Cortelli P, Calandra-Buonaura G, Morgante F. Autonomic dysfunction in progressive supranuclear palsy. J Neurol. 2022;270(1):109\u201329. https:\/\/doi.org\/10.1007\/s00415-022-11347-w","journal-title":"J Neurol"},{"issue":"1","key":"4225_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.0305-1846.2001.00374.x","volume":"28","author":"U R\u00fcb","year":"2002","unstructured":"R\u00fcb U, Del Tredici K, Fau - Schultz C, Schultz C, Fau - de Vos RAI, Arai K, Arai K, Fau - Braak H, et al. Progressive supranuclear palsy: neuronal and glial cytoskeletal pathology in the higher order processing autonomic nuclei of the lower brainstem. Neuropathol Appl Neurobiol. 2002;28(1):12\u201322. https:\/\/doi.org\/10.1046\/j.0305-1846.2001.00374.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4225_CR26","doi-asserted-by":"publisher","unstructured":"Fowler CJ, Griffiths DJ. A decade of functional brain imaging applied to bladder control. Neurourol Urodyn. 2010;29(1):49\u201355. https:\/\/doi.org\/10.1002\/nau.20740","DOI":"10.1002\/nau.20740"},{"issue":"5","key":"4225_CR27","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/nau.23496","volume":"37","author":"KA-O Kim","year":"2018","unstructured":"Kim KA-O, Jeong SJ, Kim JM. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson\u2019s disease and multiple system atrophy. Neurourol Urodyn. 2018;37(5):1724\u201330. https:\/\/doi.org\/10.1002\/nau.23496","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"4225_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0165-1838(93)90122-b","volume":"45","author":"R Sakakibara","year":"1993","unstructured":"Sakakibara R, Hattori T, Fau - Tojo M, Tojo M, Fau - Yamanishi T, Yamanishi T, Fau - Yasuda K, Yasuda K, Fau - Hirayama K, Hirayama K. Micturitional disturbance in progressive supranuclear palsy. J Auton Nerv Syst. 1993;45(2):101\u20136. https:\/\/doi.org\/10.1016\/0165-1838(93)90122-b","journal-title":"J Auton Nerv Syst"},{"issue":"5","key":"4225_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/jnnp-2018-319374","volume":"90","author":"MCB Oliveira","year":"2019","unstructured":"Oliveira MCB, Ling H, Lees AJ, Holton JL, De Pablo-Fernandez E, Warner TT. Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 2019;90(5):555\u201361. https:\/\/doi.org\/10.1136\/jnnp-2018-319374","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"4225_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.parkreldis.2011.05.020","volume":"17","author":"AD Ha","year":"2011","unstructured":"Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson\u2019s disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011;17(8):625\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.05.020","journal-title":"Parkinsonism Relat Disord"},{"key":"4225_CR31","doi-asserted-by":"publisher","first-page":"116891","DOI":"10.1016\/j.jns.2020.116891","volume":"415","author":"A Bhattacharya","year":"2020","unstructured":"Bhattacharya A, Lenka A, Stezin A, Kamble N, Pal PK. Overview of sleep disturbances and their management in Parkinson plus disorders. J Neurol Sci. 2020;415:116891. https:\/\/doi.org\/10.1016\/j.jns.2020.116891","journal-title":"J Neurol Sci"},{"issue":"5","key":"4225_CR32","doi-asserted-by":"publisher","first-page":"858","DOI":"10.4103\/aian.aian_1096_21","volume":"25","author":"SY Boini","year":"2022","unstructured":"Boini SY, Mahale R, Donaparthi S, Kamble N, Holla VV, Pal PK, et al. Sleep architecture in progressive supranuclear palsy: A Video-Polysomnography study. Ann Indian Acad Neurol. 2022;25(5):858\u201363. https:\/\/doi.org\/10.4103\/aian.aian_1096_21","journal-title":"Ann Indian Acad Neurol"},{"issue":"12","key":"4225_CR33","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1212\/WNL.0b013e3182886a76","volume":"80","author":"EE Benarroch","year":"2013","unstructured":"Benarroch EE. Pedunculopontine nucleus: functional organization and clinical implications. Neurology. 2013;80(12):1148\u201355. https:\/\/doi.org\/10.1212\/WNL.0b013e3182886a76","journal-title":"Neurology"},{"issue":"4","key":"4225_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.sleep.2008.05.004","volume":"10","author":"F Sixel-Doring","year":"2009","unstructured":"Sixel-Doring F, Schweitzer M, Mollenhauer B, Trenkwalder C. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Med. 2009;10(4):407\u201315. https:\/\/doi.org\/10.1016\/j.sleep.2008.05.004","journal-title":"Sleep Med"},{"issue":"4","key":"4225_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/mds.1120","volume":"16","author":"BF Boeve","year":"2001","unstructured":"Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease May reflect an underlying synucleinopathy. Mov Disord. 2001;16(4):622\u201330. https:\/\/doi.org\/10.1002\/mds.1120","journal-title":"Mov Disord"},{"key":"4225_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.clineuro.2014.09.014","volume":"127","author":"RP Munhoz","year":"2014","unstructured":"Munhoz RP, Teive HA. REM sleep behaviour disorder: how useful is it for the differential diagnosis of parkinsonism? Clin Neurol Neurosurg. 2014;127:71\u20134. https:\/\/doi.org\/10.1016\/j.clineuro.2014.09.014","journal-title":"Clin Neurol Neurosurg"},{"key":"4225_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.10.002","volume":"45","author":"C Pellicano","year":"2017","unstructured":"Pellicano C, Assogna F, Cellupica N, Piras F, Pierantozzi M, Stefani A, et al. Neuropsychiatric and cognitive profile of early Richardson\u2019s syndrome, progressive supranuclear Palsy-parkinsonism and Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;45:50\u20136. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.10.002","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"4225_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/mds.25872","volume":"29","author":"JR Burrell","year":"2014","unstructured":"Burrell JR, Hodges JR, Rowe JB. Cognition in corticobasal syndrome and progressive supranuclear palsy: A review. Mov Disord. 2014;29(5):684\u201393. https:\/\/doi.org\/10.1002\/mds.25872","journal-title":"Mov Disord"},{"issue":"11","key":"4225_CR39","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1007\/s00415-018-9038-x","volume":"265","author":"G Santangelo","year":"2018","unstructured":"Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M. Comparative cognitive and neuropsychiatric profiles between Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. J Neurol. 2018;265(11):2602\u201313. https:\/\/doi.org\/10.1007\/s00415-018-9038-x","journal-title":"J Neurol"},{"issue":"Pt 2","key":"4225_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/brain\/awh391","volume":"128","author":"NM Warren","year":"2005","unstructured":"Warren NM, Piggott MA, Perry EK, Burn DJ. Cholinergic systems in progressive supranuclear palsy. Brain. 2005;128(Pt 2):239\u201349. https:\/\/doi.org\/10.1093\/brain\/awh391","journal-title":"Brain"},{"issue":"6","key":"4225_CR41","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.parkreldis.2013.02.005","volume":"19","author":"A Giordano","year":"2013","unstructured":"Giordano A, Tessitore A, Corbo D, Cirillo G, de Micco R, Russo A, et al. Clinical and cognitive correlations of regional Gray matter atrophy in progressive supranuclear palsy. Parkinsonism Relat Disord. 2013;19(6):590\u20134. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.02.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"4225_CR42","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00415-014-7301-3","volume":"261","author":"F Agosta","year":"2014","unstructured":"Agosta F, Galantucci S, Svetel M, Luki\u0107 MJ, Copetti M, Davidovic K, et al. Clinical, cognitive, and behavioural correlates of white matter damage in progressive supranuclear palsy. J Neurol. 2014;261(5):913\u201324. https:\/\/doi.org\/10.1007\/s00415-014-7301-3","journal-title":"J Neurol"},{"issue":"7","key":"4225_CR43","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/mds.28568","volume":"36","author":"HA Shill","year":"2021","unstructured":"Shill HA, Zhang N, Driver-Dunckley E, Mehta S, Adler CH, Beach TG. Olfaction in neuropathologically defined progressive supranuclear palsy. Mov Disord. 2021;36(7):1700\u20134. https:\/\/doi.org\/10.1002\/mds.28568","journal-title":"Mov Disord"},{"issue":"5","key":"4225_CR44","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1212\/wnl.43.5.962","volume":"43","author":"RL Doty","year":"1993","unstructured":"Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson\u2019s disease. Neurology. 1993;43(5):962\u20135. https:\/\/doi.org\/10.1212\/wnl.43.5.962","journal-title":"Neurology"},{"key":"4225_CR45","doi-asserted-by":"publisher","first-page":"1081219","DOI":"10.3389\/fneur.2022.1081219","volume":"13","author":"WZ Hu","year":"2022","unstructured":"Hu WZ, Cao LX, Yin JH, Zhao XS, Piao YS, Gu WH, et al. Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson\u2019s disease and progressive supranuclear palsy. Front Neurol. 2022;13:1081219. https:\/\/doi.org\/10.3389\/fneur.2022.1081219","journal-title":"Front Neurol"},{"key":"4225_CR46","doi-asserted-by":"publisher","first-page":"100287","DOI":"10.1016\/j.prdoa.2024.100287","volume":"11","author":"J Ebina","year":"2024","unstructured":"Ebina J, Mizumura S, Shibukawa M, Morioka H, Nagasawa J, Yanagihashi M, et al. Comparison of MIBG uptake in the major salivary glands between lewy body disease and progressive supranuclear palsy. Clin Park Relat Disord. 2024;11:100287. https:\/\/doi.org\/10.1016\/j.prdoa.2024.100287","journal-title":"Clin Park Relat Disord"},{"issue":"5","key":"4225_CR47","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/mds.22688","volume":"25","author":"L Silveira-Moriyama","year":"2010","unstructured":"Silveira-Moriyama L, Hughes G, Church A, Ayling H, Williams DR, Petrie A, et al. Hyposmia in progressive supranuclear palsy. Mov Disord. 2010;25(5):570\u20137. https:\/\/doi.org\/10.1002\/mds.22688","journal-title":"Mov Disord"},{"issue":"5","key":"4225_CR48","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1212\/wnl.47.5.1184","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology. 1996;47(5):1184\u20139. https:\/\/doi.org\/10.1212\/wnl.47.5.1184","journal-title":"Neurology"},{"issue":"2","key":"4225_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/mdc3.12382","volume":"4","author":"L Almeida","year":"2017","unstructured":"Almeida L, Ahmed B, Walz R, De Jesus S, Patterson A, Martinez-Ramirez D, et al. Depressive symptoms are frequent in atypical parkinsonian disorders. Mov Disord Clin Pract. 2017;4(2):191\u20137. https:\/\/doi.org\/10.1002\/mdc3.12382","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"4225_CR50","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.psychres.2013.08.045","volume":"210","author":"A Gerstenecker","year":"2013","unstructured":"Gerstenecker A, Duff K, Mast B, Litvan I. Behavioral abnormalities in progressive supranuclear palsy. Psychiatry Res. 2013;210(3):1205\u201310. https:\/\/doi.org\/10.1016\/j.psychres.2013.08.045","journal-title":"Psychiatry Res"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04225-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:06:20Z","timestamp":1747641980000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04225-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4225"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04225-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol conformed to the principles of the declaration of Helsinki and was approved by by the Medical Ethics Committee of the Fujian Medical University Union Hospital (approval number: 2023KJT075). All participants and\/or their legal guardian gave their written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"213"}}